相关实验视频

Updated: Apr 30, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

一种先进的综合性突变细胞类型特异模型,用于预测黑色素瘤中抗PD-1治疗效果

Wei Sun¹, Yu Zhu², Zijian Zou¹

¹Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P. R. China.

|March 20, 2024

概括

研究人员确定了四个细胞子组,这些细胞子组影响了在晚期黑色素瘤中抗PD-1治疗的有效性. 这一发现有助于理解耐药性,并指导临床药物管理,以获得更好的患者结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

晚期黑色素瘤通常对抗PD-1疗法等免疫检查点抑制剂 (ICI) 的反应有限.
瘤耐药性与瘤细胞,免疫细胞和纤维细胞的转录性变化有关,损害了抗瘤免疫力.
特定的细胞子组及其影响ICI疗效的相互作用需要进一步确定.

研究的目的:

为了确定与晚期黑色素瘤抗PD-1治疗有效性相关的细胞子组.
为了阐明驱动抗瘤免疫力的细胞-细胞通信网络.
开发一种用于评估抗PD-1治疗疗效的预测模型.

主要方法:

在新辅助抗PD-1疗法之前和之后,对瘤组织的单核测序.
使用多色免疫光染色和公共数据集进行验证.
对细胞间通信网络的分析.

主要成果:

确定了与抗PD-1治疗反应相关的四个不同的细胞子组.
描述了涉及这些子组的细胞-细胞通信网络,有助于抗瘤免疫力.
基于这些子组开发了一种新的预测模型,用于评估治疗疗效.

结论:

这项研究揭示了黑色素瘤中抗PD-1疗法耐药性的关键机制.
研究结果提供了关于促进抗瘤免疫力的细胞相互作用的见解.
开发的模型为优化黑色素瘤患者临床药物管理提供了潜在的指导.

关键词:

这是一种抗PD-1药物.免疫检查点抑制剂免疫检查点抑制剂机器学习是机器学习.恶性黑色素瘤是一种恶性黑色素瘤.瘤微环境是一个微环境.

更多相关视频

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...